| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 11, 2013
MINNEAPOLIS - Feb. 11, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2013 on Tuesday, February 19, 2013. A news...
-
Feb 5, 2013Rubio ayuda a los visitantes de la página web a salvar una vida "virtual" en HeartRescueNow.com
MINNEAPOLIS, 5 de febrero, 2013 - Ricky Rubio, la estrella de los Minnesota Timberwolves se une a la fundación Medtronic durante este mes de febrero para salvar la vida de jóvenes de todo el...
-
Feb 4, 2013Next-Generation ICDs Offer Patients Proven Treatment Performance, Increased Longevity, Improved Comfort
MINNEAPOLIS - February 4, 2013 - Medtronic today announced CE (Conformité Européenne) Mark of the Evera® portfolio of implantable cardioverter-defibrillators (ICD). With increased longevity and...
-
Feb 3, 2013Rubio Helps Web Visitors Save a "Virtual" Life at HeartRescueNow.com
MINNEAPOLIS, February 5, 2013 -Minnesota Timberwolves basketball star Ricky Rubio joins the Medtronic Foundation this February in saving young lives worldwide from sudden cardiac arrest (SCA)....
-
Jan 30, 2013
TOLOCHENAZ AND MINNEAPOLIS - January 30, 2013 - Medtronic, Inc. (NYSE: MDT) today introduced in Europe the first and only implantable neurostimulation systems indicated for use in the treatment of...
-
Jan 30, 2013Strategic Alliance to Leverage Best of Both Companies to Reach Cardiovascular Patients in China and Other Emerging Markets
MINNEAPOLIS and Shenzhen - January 30, 2013 - Medtronic, Inc. (NYSE:MDT) and LifeTech Scientific Corporation (8122:HK) today announced the closing of a transaction creating a strategic alliance...
-
Jan 28, 2013First Patients Treated in Global Clinical Trial Evaluating Impact of Therapy on Predominant Low Back Pain
MINNEAPOLIS - January 28, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the start of PROMISE, a Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low...
-
Jan 24, 2013Self-Expanding Peripheral Device Gets CE Mark for Superficial Femoral and Proximal Popliteal Arteries
MINNEAPOLIS -- Jan. 24, 2013 -- Expanding its role in the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced the CE (Conformité Européene) mark and international...
-
Jan 23, 2013Milestone in IN.PACT SFA II Brings FDA Submission for Promising Interventional Treatment of Peripheral Artery Disease One Step Closer in U.S.
MINNEAPOLIS -- Jan. 23, 2013 -- Medtronic, Inc. (NYSE: MDT), today announced completion of enrollment in IN.PACT SFA II, the U.S. arm of its clinical study for the IN.PACT Admiral drug-eluting...
-
Jan 16, 2013Medtronic Announces First Patient Implant in REVEAL AF Clinical Trial
MINNEAPOLIS - January 16, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the first patient implant for the REVEAL AF (Incidence of AF in High Risk Patients) Clinical Trial, which through...